NCT03082482 (AVAST-HIV) is a NA clinical trial of Self-help materials in Smoking Cessation, sponsored by University of Oklahoma.

Who is sponsoring NCT03082482?

NCT03082482 is sponsored by University of Oklahoma.

What drugs are being tested in NCT03082482?

Interventions in NCT03082482: Self-help materials, nicotine patch, Counseling, Smartphone-delivered automated treatment.

What condition does NCT03082482 study?

NCT03082482 studies Smoking Cessation.

Is NCT03082482 still recruiting?

NCT03082482 is currently completed. Last updated 11 April 2018.

Last reviewed 2018-04-11 · How we verify

NCT03082482: AVAST-HIV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Smartphone-delivered Automated Video-assisted Smoking Treatment for People Living With HIV

Completed NA Last updated 11 April 2018

What this trial tests

NA trial testing Self-help materials in Smoking Cessation in 20 participants. Completed in 31 December 2017.

Timeline

15 May 2017

Primary endpoint
19 May 2017

31 December 2017

Quick facts

Lead sponsor	University of Oklahoma
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	15 May 2017
Primary completion	19 May 2017
Estimated completion	31 December 2017
Sites	1 location across United States

Drugs / interventions tested

Self-help materials
nicotine patch (nicotine-patch) — full drug profile →
Counseling
Smartphone-delivered automated treatment

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

University of Oklahoma

Who can join

Adults 18 to 99, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed pilot study seeks to address the smoking treatment needs of people living with HIV/AIDS (PLWHA) by evaluating the feasibility and preliminary efficacy of a smartphone delivered automated video-assisted smoking treatment (AVAST). AVAST will enable smoking cessation treatment content to be presented with voice/audio, images, videos, and text in an interactive, structured format anytime and anywhere. This automated treatment approach is designed to enhance treatment engagement and facilitate abstinence from smoking among PLWHA. Participants will be recruited from the University of Oklahoma Health Sciences Center (OUHSC) clinics providing care to HIV+ individuals (e.g., the Infectious Diseases Institute).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Targeted client communication via mobile devices for improving sexual and reproductive health.
Palmer MJ, Henschke N, Villanueva G, Maayan N, et al · · 2020 · cited 32× · PMID 32779730 · DOI 10.1002/14651858.cd013680
Interventions for tobacco use cessation in people living with HIV.
Mdege ND, Shah S, Dogar O, Pool ER, et al · · 2024 · cited 6× · PMID 39101506 · DOI 10.1002/14651858.cd011120.pub3

Verify or expand the search:

Other trials of Self-help materials

Trials testing the same drug.

NCT04965181 — Mindfulness-based Smoking Cessation Enhanced With Mobile Technology · NA · completed
NCT03060278 — Smartphone-delivered Automated Video-assisted Smoking Treatment for Patrons of a Food Resource Center · Phase 4 · completed

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other University of Oklahoma trials

Trials by the same sponsor.

NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
NCT07494773 — Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection · Phase 1, PHASE2 · not yet recruiting
NCT07014605 — Smoking Cessation Program for Lao People With HIV · NA · not yet recruiting
NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07491653 — Fiber mHealth Intervention for Prediabetes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03082482 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oklahoma
Last refreshed: 11 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03082482.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing